curcumin: reintroduced therapeutic agent from traditional medicine for alcoholic liver disease

نویسندگان

hamid reza rahimi student research committee, department of modern sciences & technologies, school of medicine, mashhad university of medical sciences, mashhad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)

mahmoud reza jaafari nanotechnology research center, school of pharmacy, mashhad university of medical science, mashhad, iran

amir hooshang mohammadpour department of clinical pharmacy and pharmaceutical research center, school of pharmacy, mashhad university of medical science, mashhad, iran

khalil abnous pharmaceutical research center, school of pharmacy, mashhad university of medical sciences, mashhad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)

چکیده

alcoholic liver disease (ald) is the main cause of chronic liver disease across the world and can lead to fibrosis and cirrhosis. the etiopathogenesis of ald is related to ethanol-induced oxidative stress, glutathione reduction, abnormal methionine metabolism, malnutrition, and production of endotoxins that activate kupffer cells. curcumin is an active ingredient of the rhizome of turmeric. the substance is shown to have minor adverse effects. as the substance possess low bioavailability in free formulation, different strategies has been conducted to improve its bioavailability which resulted in production of nanomiscels and nanoparticles. curcumin can provide protection for the liver against toxic effects of alcohol use. several studies showed curcumin blocks endotoxin-mediated activation of nf-κb and suppresses the expression of cytokines, chemokines, cox-2, and inos in kupffer cells. according to the molecular studies, curcumin inhibits nf-κb signaling pathway, regulates cytokines production and modulates immune response. it has been shown that curcumin can suppress gene expression, especially cytokines genes resulting in down-regulation of tumor necrosis factor-α (tnf-α), interleukin 1 (il-1), il-6, il-8, adhesion molecules (icam, vcam) and c-reactive protein. hence, curcumin can have therapeutic effects on the majority of chronic inflammatory diseases such as asthma, bronchitis, inflammatory bowel disease, rheumatoid arthritis, ald, fatty liver, and allergy.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Curcumin: Reintroduced Therapeutic Agent from Traditional Medicine for Alcoholic Liver Disease

Alcoholic liver disease (ALD) is the main cause of chronic liver disease across the world and can lead to fibrosis and cirrhosis. The etiopathogenesis of ALD is related to ethanol-induced oxidative stress, glutathione reduction, abnormal methionine metabolism, malnutrition, and production of endotoxins that activate Kupffer cells. Curcumin is an active ingredient of the rhizome of turmeric. The...

متن کامل

Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease.

Non-alcoholic fatty liver disease affects approximately one-third of the population worldwide, and its incidence continues to increase with the increasing prevalence of other metabolic disorders such as type 2 diabetes. As non-alcoholic fatty liver disease can progress to liver cirrhosis, its treatment is attracting greater attention. The pathogenesis of non-alcoholic fatty liver disease is clo...

متن کامل

Liver Transplantation for Alcoholic Liver Disease

Alcohol consumption, in particular harmful alcohol use related to Alcohol Use Disorders (AUD) accounts for 3.8% of global mortality and 4.6% of Disability-Adjusted Life Years (DALYs) worldwide [1]. A total of 9.5% of alcohol-related DALYs is due to Alcoholic Liver Disease (ALD) [2]. At present alcohol still represents the most common cause of liver cirrhosis in the Western countries [3]. The de...

متن کامل

Orthotopic liver transplantation for alcoholic liver disease.

Alcohol abuse is the most common cause of end-stage liver disease in the United States, but many transplant centers are unwilling to accept alcoholic patients because of their supposed potential for recidivism, poor compliance with the required immunosuppression regimen and resulting failure of the allograft. There is also concern that alcohol-induced injury in other organs will preclude a good...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
asia pacific journal of medical toxicology

جلد ۴، شماره ۱، صفحات ۲۵-۳۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023